Modeling early retinal development with human embryonic and induced pluripotent stem cells.
Human pluripotent stem cells have the potential to provide comprehensive model systems for the earliest stages of human ontogenesis. To serve in this capacity, these cells must undergo a targeted, stepwise differentiation process that follows a normal developmental timeline. Here we demonstrate the ability of both human embryonic stem cells (hESCs) and induced pluripotent stem (iPS) cells to meet these requirements for human retinogenesis. Upon differentiation, hESCs initially yielded a highly enriched population of early eye field cells. Thereafter, a subset of cells acquired features of advancing retinal differentiation in a sequence and time course that mimicked in vivo human retinal development. Application of this culture method to a human iPS cell line also generated retina-specific cell types at comparable times in vitro. Lastly, altering endogenous signaling during differentiation affected lineage-specific gene expression in a manner consistent with established mechanisms of early neural and retinal cell fate determination. These findings should aid in the investigation of the molecular events governing retinal specification from human pluripotent stem cells.
Meyer
Jason S
JS
Stem Cell Research Program, Waisman Center, Departments of Anatomy and Neurology, University of Wisconsin-Madison, 1500 Highland Avenue, Madison, WI 53705, USA.
Shearer
Rebecca L
RL
Capowski
Elizabeth E
EE
Wright
Lynda S
LS
Wallace
Kyle A
KA
McMillan
Erin L
EL
Zhang
Su-Chun
SC
Gamm
David M
DM
D002454:Cell Differentiation; D053595:Embryonic Stem Cells / Q000166:cytology* / Q000378:metabolism; D006801:Humans; D007150:Immunohistochemistry; D008954:Models, Biological; D010641:Phenotype; D039904:Pluripotent Stem Cells / Q000166:cytology* / Q000378:metabolism; D012160:Retina / Q000196:embryology / Q000254:growth & development*
Nature. 2009 Jan 15;457(7227):277-80
19098894
Cloning Stem Cells. 2004;6(3):217-45
15671670
Neurosci Lett. 2009 Jul 24;458(3):126-31
19379795
Dev Ophthalmol. 1992;24:1-142
1628748
Nature. 1998 Jan 22;391(6665):357-62
9450748
Annu Rev Cell Dev Biol. 2001;17:255-96
11687490
Science. 1993 Oct 29;262(5134):713-8
8235591
Stem Cells. 2006 Feb;24(2):246-57
16123388
Invest Ophthalmol Vis Sci. 1997 Jun;38(7):1293-303
9191592
Invest Ophthalmol Vis Sci. 2008 Feb;49(2):788-99
18235029
Cell Stem Cell. 2009 Jan 9;4(1):73-9
19128794
Exp Neurol. 2008 Dec;214(2):347-61
18926821
Development. 2004 Oct;131(20):5139-52
15459106
Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3088-93
9096350
Development. 2004 Nov;131(22):5515-25
15509763
Neuron. 1997 Nov;19(5):1017-30
9390516
Development. 2005 Jan;132(1):177-87
15576400
Int J Dev Biol. 2004;48(8-9):761-70
15558469
Development. 2003 Nov;130(21):5155-67
12944429
BMC Dev Biol. 2005 Jul 19;5:13
16029501
Nature. 2006 Nov 9;444(7116):203-7
17093405
Development. 1997 Feb;124(3):603-15
9043075
Proc Natl Acad Sci U S A. 2006 Aug 22;103(34):12769-74
16908856
Cell Mol Life Sci. 2000 Feb;57(2):186-94
10766016
Genes Dev. 2005 May 15;19(10):1129-55
15905405
Development. 2007 Oct;134(19):3483-93
17728349
Curr Opin Neurobiol. 2006 Feb;16(1):13-9
16413771
Stem Cells. 2007 Jun;25(6):1511-20
17332508
Cell. 2007 Nov 30;131(5):861-72
18035408
Development. 2008 Mar;135(6):1169-78
18272592
Cell. 2008 Sep 5;134(5):877-86
18691744
Nat Biotechnol. 2008 Feb;26(2):187-8
18259172
Brain Res. 2008 Feb 4;1192:5-16
17692298
Nat Biotechnol. 2008 Feb;26(2):215-24
18246062
Science. 2007 Dec 21;318(5858):1917-20
18029452
Genes Dev. 2008 Jan 15;22(2):152-65
18198334